As Becton Dickinson & Co (NYSE:BDX) Price Declined, Mackenzie Financial Corp Upped Position

May 16, 2018 - By Charla Downs

Becton, Dickinson and Company (NYSE:BDX) Corporate LogoDuring Q4 2017 the big money sentiment increased to 1.55. That’s change of 0.62, from 2017Q3’s 0.93. 50 investors sold all, 294 reduced holdings as BDX ratio improved. 386 grew stakes while 147 funds acquired stakes. Funds hold 215.77 million shares thus 9.23% more from 2017Q3’s 197.53 million shares. Skba Cap Mgmt Lc reported 1,400 shs. Veritable Limited Partnership accumulated 12,384 shs. Moreover, First Personal Fincl Service has 0.01% invested in Becton, Dickinson and Company (NYSE:BDX). Harbour Invest Limited Liability holds 11,095 shs or 1.67% of its capital. Da Davidson & holds 0.12% in Becton, Dickinson and Company (NYSE:BDX) or 26,636 shs. Cidel Asset Management owns 967 shs for 0.01% of their capital. Renaissance Tech Lc holds 0.49% or 2.07M shs in its capital. Moreover, Capital Financial Advisers Ltd has 0.38% invested in Becton, Dickinson and Company (NYSE:BDX). Glob X Mngmt Communications Lc accumulated 0.03% or 5,897 shs. Tower Rech Capital Ltd (Trc) reported 10,827 shs stake. Wellington Shields & Limited Liability Co reported 0.29% in Becton, Dickinson and Company (NYSE:BDX). Barbara Oil Co accumulated 5,000 shs. Fil Ltd has invested 0.04% in Becton, Dickinson and Company (NYSE:BDX). Westchester Cap Mgmt Ltd Liability accumulated 251,696 shs or 2.11% of the stock. Levin Cap Strategies L P, New York-based fund reported 63,040 shs.

BDX registered $4.78 million net activity with 1 insider buy and 5 insider sales since February 23, 2018. Another trade for 4,048 shs valued at $910,726 was sold by Borzi James W. The insider RING TIMOTHY M sold $38,416. On Tuesday, February 27 $1.21 million worth of stock was sold by Gallagher John E. 1,877 Becton, Dickinson and Company (NYSE:BDX) shs with value of $426,079 were sold by Polen Thomas E Jr. On Monday, May 7 Melcher David F bought $112,535 worth of Becton, Dickinson and Company (NYSE:BDX).

Mackenzie Financial Corp’s stake in Becton Dickinson & Co (NYSE:BDX) was upped by 18.75% based on its latest 2018Q1 report with the SEC. Becton Dickinson & Co (NYSE:BDX) stock Sank 1.94% while Mackenzie Financial Corp bought 180,176 shares. In 2018Q1, Mackenzie Financial Corp held 1.14 million shares of Becton Dickinson & Co (NYSE:BDX), priced at $247.28 million, up from 960,926 last quarter. $60.09 billion is the MC of Becton Dickinson & Co. The stock increased 0.05% or $0.12 during the last trading session, reaching $224.87.Becton, Dickinson and Company has 1.20 million shares volume, 3.28% up from normal. BDX is uptrending and has moved 15.92% since May 17, 2017. The stock outperformed the S&P 500 by 4.37%.

Mackenzie Financial Corp operates about $61.70 billion and $39.23 billion US longs. According to a filing the fund decreased its stake in Canadian Natl Ry Co (NYSE:CNI) by 626,289 shares to 5.93M shares, valued at $433.71 million in 2018Q1. Mackenzie Financial Corp cut its stake in Bce Inc (NYSE:BCE) and reduced Charles Riv Labs Intl Inc (NYSE:CRL) position by 351,447 shares for a total of 719,731 shares.

Mackenzie Financial Corp is a Ontario, Canada-based hedge fund with more than $61.70 billion AUM in March, 2014. This fund invests only a small percentage of its assets in equities and options. Mackenzie Financial Corp is the 80th largest hedge fund in our database. Taken from Mackenzie Financial latest Adv, the fund reported to have 1006 full and part-time employees. Among which 70 performing investment advisory and research functions. The hedge fund had more than 200 clients.

Becton, Dickinson and Company (NYSE:BDX) Ratings Coverage

Total analysts of 12 have positions in Becton Dickinson (NYSE:BDX) as follows: 9 rated it a “Buy”, 0 with “Sell” and 3 with “Hold”. The positive are 75%. Since December 14, 2017 according to StockzIntelligence Inc Becton Dickinson has 13 analyst reports. On Thursday, February 8 the rating was maintained by RBC Capital Markets with “Hold”. On Wednesday, December 20 the rating was maintained by Cowen & Co with “Buy”. On Tuesday, February 6 the company was maintained by Jefferies. On Friday, December 29 Deutsche Bank maintained Becton, Dickinson and Company (NYSE:BDX) rating. Deutsche Bank has “Buy” rating and $260.0 target. On Friday, January 5 the firm has “Hold” rating given by Citigroup. On Tuesday, April 10 the rating was upgraded by Citigroup to “Buy”. In Wednesday, February 7 report Morgan Stanley maintained the stock with “Equal-Weight” rating. On Tuesday, February 6 Piper Jaffray maintained the shares of BDX in report with “Buy” rating.

Becton, Dickinson and Company develops, makes, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide.The company has $60.09 billion market cap. It operates in two divisions, BD Medical and BD Life Sciences.Currently it has negative earnings. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems.

Becton, Dickinson and Company (NYSE:BDX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.